2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lung Neoplasms
28
Ovarian Neoplasms
27
Fallopian Tube Neoplasms
24
Carcinoma, Non-Small-Cell Lung
21
Colorectal Neoplasms
17
Pancreatic Neoplasms
11
Glioblastoma
11
Melanoma
10
Carcinoma, Renal Cell
10
Carcinoma, Hepatocellular
10
Breast Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Lymphoma, Large B-Cell, Diffuse
8
Urinary Bladder Neoplasms
7
Neoplasm Metastasis
7
Colonic Neoplasms
7
Brenner Tumor
7
Uterine Cervical Neoplasms
6
Rectal Neoplasms
6
Prostatic Neoplasms
6
Mycosis Fungoides
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Brain Neoplasms
6
Triple Negative Breast Neoplasms
5
Multiple Myeloma
5
Lymphoma, T-Cell, Cutaneous
5
Sezary Syndrome
4
Sarcoma
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Interventions
Ifosfamide
30
Methotrexate
29
Doxorubicin
26
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
Specimen Handling
10
cabozantinib
9
apatinib
9
X-Rays
9
Carboplatin
9
fludarabine
8
Radiotherapy
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Drug Therapy
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Phantoms, Imaging
7
Biopsy
7
mifamurtide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Disulfides
×
Clear all
NCT04668300
2026-04-15
DOSa
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
75 enrolled